All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 129 of 206 pages ‹ First < 127 128 129 130 131 > Last ›
HSL941
Faunce T.
Cashing in on our pharmaceutical expertise
The Canberra Times 2005 Apr 11
HSL944
Herper M.
Breast Implants, Bextra And Fair Disclosure
Forbes.com 2005 Apr 11
HSL947
Cunningham M.
300 deaths blamed on arthritis pill
The Herald Sun 2005 Apr 11
HSL948
Editorial .
The Price of NIH Credibility
THE LOS ANGELES TIMES 2005 Apr 11
HSL1091
FDA Talk Paper
FDA 2005 Apr 11
HSL16247
Holmes J
Total Recall
Four Corners : ABC (Australia) 2005
http://www.abc.net.au/4corners/content/2005/s1340327.htm
HSL686
Carlisle W.
What Went Wrong with Vioxx?
Radio National (Australian Broadcasting Commission) 2005 Apr 10
http://www.abc.net.au/rn/talks/bbing/stories/s1343699.htm
HSL964
Associated Press.
Pa. gov't pharmacist fined for ethics violations, ties to Pfizer
WKYT 2005 Apr 10
HSL969
Waters R.
Medicating Aliah: When state mental health officials fall under the influence of Big Pharma, the burden falls on captive patients. Like this 13-year-old girl.
Mother Jones 2005 Apr 10
HSL2668
Seniors and Drugs: Prescribed to death
CBC News Online 2005 Apr 10
http://www.cbc.ca/news/background/seniorsdrugs/index.html
HSL5302
Altman DG, Bland JM.
Treatment allocation by minimisation.
BMJ 2005 Apr 9;330:(7495):843
http://bmj.bmjjournals.com/cgi/content/full/330/7495/843
HSL5590
Shann F.
Non-specific effects of vaccination: vaccines have non-specific (heterologous) effects.
BMJ 2005 Apr 9;330:(7495):844
http://bmj.bmjjournals.com/cgi/content/full/330/7495/844
HSL938
Harris G.
F.D.A. Announces Strong Warnings for Painkillers
THE NEW YORK TIMES 2005 Apr 8
HSL939
Berenson A.
Pfizer Loses One Remedy for Its Slump
The New York Times 2005 Apr 8
HSL1099
Widow Fights Zoloft-Maker's Attempt to Throw Out Court Claim that Zoloft Caused Husband's Suicide: Minnesota Attorney General Argues For Her Right to Pursue Claim
Baum Hedlund 2005 Apr 8
HSL20149
Cole L
US pharma ads increase risk awareness
Medical Observer 2005 Apr 813
HSL942
Prnewswire .
New FDA Labeling for Pfizer's Celebrex and All Other NSAIDs to Reflect Similar Cardiovascular Profile: Pfizer Separately Agrees to Suspend Sales of Bextra Due to FDA Evaluation of Risks of Rare But Serious Skin Reactions
PRNewswire 2005 Apr 7
HSL1100
FDA announces series of changes to the class of marketed non-steriodal anti-inflammatory drugs (NSAIDs)
FDA 2005 Apr 7
HSL1558
Fenam -.
Especialistas criticam propagandas de medicamentos
: FENAM - Federacao Nacional dos Medicos 2005 Apr 7
HSL949
Unhealthy Ethics
The Washington Post 2005 Apr 6
HSL976
Kerr K.
Medicine or marketing?: Pfizer plan to sell Lipitor mixed with a second drug draws fire from some medical experts Dowling College
Newsday.com 2005 Apr 6
HSL1556
Agencia Nacional
Especialistas criticam propagandas de medicamentos
: Agencia Nacional de Vigilancia Saitaria 2005 Apr 6
http://www.anvisa.gov.br/divulga/noticias/2005/060405_6.htm
HSL951
Hensley S.
Follow The Money: Doctors, Drug Makers Too Cozy? New Guidelines Fuel the Debate
The Wall Street Journal 2005 Apr 5
HSL953
Hamilton D.
Silent Treatment How Genentech, Novartis Stifled A Promising Drug: Biotech Firm Tried to Pursue Peanut-Allergy Injection, But Contract Got in Way
THE WALL STREET JOURNAL 2005 Apr 5
HSL955
Meikle J.
NHS links with drug firms under scrutiny
The Guardian 2005 Apr 5
HSL1096
Revised Advisory Committee Structure
MHRA 2005 Apr 5
HSL1094
Response to Health Select Committee report
MHRA 2005 Apr 4
HSL935
Hinsliff G.
Drugs firms 'creating ills for every pill': Expensive new medicines are oversold when cheaper therapies or prevention would work better, say MPs
The Observer 2005 Apr 3
HSL3789
Komesaroff P.
Ethical issues in the relationships involving medicine and industry: evolving problems require evolving.
Intern Med J 2005 Apr 01;35:(4):203-5
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3046&uid=15836496&db=pubmed&url=http://www.blackwell-synergy.com/openurl?genre=article&sid=nlm:pubmed&issn=1444-0903&date=2005&volume=35&issue=4&spage=203
HSL3793
Warren CS, Strauss J, Taska JL, Sullivan SJ.
Inspiring or dispiriting? The effect of diet commercials on snack food consumption in high school and college-aged women.
Int J Eat Disord 2005 Apr 01;37:(3):266-70
http://www3.interscience.wiley.com/cgi-bin/abstract/110441236/ABSTRACT?CRETRY=1&SRETRY=0
HSL3794
Longstaff C, Thelwell C, Whitton C.
Regulatory frameworks in developing countries.
Nat Biotechnol 2005 Apr 01;23:(4):413
http://www.nature.com/doifinder/10.1038/nbt0405-413a
HSL4549
Morgan S, Bassett KL, Wright JM, Yan L.
First-line first? Trends in thiazide prescribing for hypertensive seniors
PLoS Med 2005 Apr 00;2:(4):
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=15839739
HSL4991
Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ.
The global threat of counterfeit drugs: why industry and governments must communicate the dangers.
PLoS Med 2005 Apr 01;2:(4):e100
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020100
HSL5156
Manchester A.
Counterfeit medicines kill.
Nurs N Z 2005 Apr 01;11:(3):10
HSL5297
Allison JJ, Kiefe CI, Wall T, Casebeer L, Ray MN, Spettell CM, Hook EW 3rd, Oh MK, Person SD, Weissman NW.
Multicomponent Internet continuing medical education to promote chlamydia screening.
Am J Prev Med 2005 Apr 01;28:(3):285-90
http://linkinghub.elsevier.com/retrieve/pii/S0749-3797(04)00366-6
HSL637
Mansfield PR, Vitry A.
Rofecoxib withdrawal.
Australian Prescriber 2005 Apr;28:(2):30
http://www.australianprescriber.com/index.php?content=/magazines/vol28no2/28_33_letters.htm
HSL1600
Berliner N.
Customized Detailing through Physician Categorization
2005 Apr;
HSL1813
Stanley AG, Jackson D, Barnett DB.
The teaching of drug development to medical students: collaboration between the pharmaceutical industry and medical school.
Br J Clin Pharmacol 2005 Apr;59:(4):464-74
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2125.2005.02374.x
HSL1826
Watson PY, Khandelwal AK, Musial JL, Buckley JD.
Resident and faculty perceptions of conflict of interest in medical education.
J Gen Intern Med 2005 Apr;20:(4):357-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.04075.x
HSL1884
Rieger HJ.
[Sponsoring of physicians in private practice]
Z Arztl Fortbild Qualitatssich. 2005 Apr;99:(2):161-4
HSL2035
Kerridge I, Maguire J, Newby D, McNeill PM, Henry D, Hill S, Day R, Macdonald G, Stokes B, Henderson K.
Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations.
Intern Med J 2005 Apr;35:(4):206-10
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1444-0903.2004.00799.x
HSL2116
De Conno F, Ripamonti C, Brunelli C.
Opioid purchases and expenditure in nine western European countries: are we killing off morphine?
Palliat Med. 2005 Apr;19:(3):179-84
http://www.ncbi.nlm.nih.gov/pubmed/15920930
HSL2275
Adair R, Callies L, Lageson J, Hanzel KL, Streitz SM, Gantert SC.
Posting guidelines: a practical and effective way to promote appropriate hypertension treatment.
Jt Comm J Qual Patient Saf 2005 Apr;31:(4):227-32
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
HSL3746
Macias W, Lewis LS, Smith TL.
Health-related message boards/chat rooms on the Web: discussion content and implications for pharmaceutical sponsorships.
J Health Commun 2005 Apr-May;10:(3):209-23
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3396&uid=16036729&db=pubmed&url=http://journalsonline.tandf.co.uk/Index/10.1080/10810730590934235
HSL3795
Dong X, Fetterolf D.
Specialty pharmacy: an emerging area of interest for medical management.
Dis Manag 2005 Apr;8:(2):73-85
HSL4605
Faunce TS, Tomossy GF.
The UK House of Commons report on the influence of the pharmaceutical industry: lessons for equitable access to medicines in Australia.
Monash Bioeth Rev 2005 Apr;24:(2):38-42
HSL9812
Figert AE.
Premenstrual syndrome as scientific and cultural artifact.
Integr Physiol Behav Sci 2005 Apr-Jun;40:(2):102-13
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17393679&query_hl=12&itool=pubmed_DocSum
HSL11561
Doroshow J.
The role of the National Cancer Institute in drug development.
Clin Adv Hematol Oncol 2005 Apr;3:(4):257-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=16166997
HSL15545
Agterberg R.
4th Annual Pharmaceutical Marketing Conference 'Marketing ROI for Pharma'
Journal of Medical Marketing 2005 Apr;5:(2):182
http://www.palgrave-journals.com/jmm/journal/v5/n2/abs/5040226a.html
HSL16750
Ardati A, Stolley P, Knapp DE, Wolfe SM, Lurie P.
Statin-associated rhabdomyolysis.
Pharmacoepidemiol Drug Saf 2005 Apr;14:(4):287
http://www3.interscience.wiley.com/journal/110432170/abstract?CRETRY=1&SRETRY=0
HSL1551
Burton R.
How Merck stacked the Vioxx deck
Salon.com 2005 Mar 31
HSL932
Metherell M.
Exposed: drugs price scandal
The Sydney Morning Herald 2005 Mar 30
HSL931
12.5 per cent price cut for generic drugs
Australian Government Department of Health and Ageing 2005 Mar 29
HSL3349
Larson RJ, Schwartz LM, Woloshin S, Welch HG.
Advertising by academic medical centers.
Arch Intern Med 2005 Mar 28;165:(6):645-51
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15795340&query_hl=8&itool=pubmed_docsum
HSL927
Toneguzzi M.
Drugs 'overused' in care centres: Tranquillizers given to a third of residents
Calgary Herald 2005 Mar 27
HSL920
Davey M, Harris G.
Family Wonders if Prozac Prompted School Shootings
The New York Times 2005 Mar 26
HSL923
The Associated Press.
F.D.A. Approves Monthly Osteoporosis Pill
The New York Times 2005 Mar 26
HSL924
Lenzer J.
Researcher to be sacked after reporting high rates of ADHD
British Medical Journal 2005 Mar 26
HSL909
Ives N.
Consumers Are Looking Past Commercials to Study Prescription Drugs
The New York Times 2005 Mar 25
HSL910
Haga C.
Relatives: Did meds play a role?
The Star Tribune 2005 Mar 25
HSL913
Harden B, Hedgpeth D.
Minnesota Killer Chafed at Life On Reservation: Teen Faced Cultural Obstacles And Troubled Family History
The Washington Post 2005 Mar 25
HSL915
Harris G.
Citizens' Group Wants Hyperactivity Drug Taken Off the Market
The New York Times 2005 Mar 25
HSL917
Hearn K.
Brazil's Bold Move
AlterNet 2005 Mar 25
HSL918
Wilde MATHEWS.
FDA Issues Drug-Safety Guidelines Withdrawals From Market Of Approved Medicines Add to Pressure on Agency
THE WALL STREET JOURNAL 2005 Mar 25
HSL925
Helms M.
Shooting fuels debate over safety of Prozac for teens
Minnesota Public Radio 2005 Mar 25
HSL20044
Cole L
Hospitality, GP software rules under fire
Medical Observer 2005 Mar 2510
HSL906
Olivieri N.
Physicians influenced
2005 Mar 24
HSL907
Connolly C, Hedgpeth D.
Teen shooter was taking Prozac: Hospitalized for being suicidal
The Washington Post 2005 Mar 24
HSL908
McNeil D.
India Alters Law on Drug Patents
The New York Times 2005 Mar 24
HSL912
Katz C.
New York Daily News
Minn. Massacre teen taking Prozac 2005 Mar 24
HSL914
Associated Press.
Update 1: Drug Companies Launch Ad Campaign
Forbes.com 2005 Mar 24
HSL928
PhRMA Welcomes Passage of Patent Bill in India
Health Orbit 2005 Mar 23
HSL936
Adams L.
How Ritalin became poor man’s cocaine
The Herald 2005 Mar 23
HSL905
Schumacher A.
Doctors and dinners
2005 Mar 22
HSL6206
The UK House of Commons Health Select Committee
The Influence of the Pharmaceutical Industry
London: The Stationery Office Limited 2005 Mar 22
http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf
HSL7446
US FDA Center for Drug Evaluation and Research
CDER NDAs Approved in Calendar Years 1990-2004 by Therapeutic Potential and Chemical Type
Rockville, MD: US FDA Center for Drug Evaluation and Research 2005 Mar 22
http://www.fda.gov/cder/rdmt/pstable.htm
HSL922
Payne D.
Researcher admits faking data: 'Egregiousness' of conduct over almost 15 years leads to first-ever lifetime ban on US grants
The Scientist 2005 Mar 21
HSL1101
Minnesota Attorney General Supports Widow in Zoloft Suicide Case
Baum Hedlund 2005 Mar 21
HSL900
Gooznews .
Crawford's pledge
GoozNews 2005 Mar 19
HSL901
Burnside S.
Would you run `Julie' ad campaign?
The Toronto Star 2005 Mar 19
HSL903
Blackwell T.
Drug firm's violations of ethics 'unprecedented': Industry code: Company paid for doctors' trips to conference on French Riviera
The National Post 2005 Mar 19
HSL896
Alonso-zaldivar R.
It's a Maybe for Drug Safety Unit: Nominee to head FDA, pressed by senators, says he's open to discussing an independent office.
THE LOS ANGELES TIMES 2005 Mar 18
HSL897
Associated Press.
Bush FDA Choice Rattles Advocacy Groups
The New York Times 2005 Mar 18
HSL898
Wilde MATHEWS.
FDA to Revamp Disclosure Process
THE WALL STREET JOURNAL 2005 Mar 18
HSL899
Goldberg C, Allen S.
Researcher admits fraud in grant data Ex-Vermont scientist won nearly $3m from US
THE BOSTON GLOBE 2005 Mar 18
HSL5346
Levine S.
Eminent domain urged as tool to cut drug costs
Washington Post 2005 Mar 17
http://www.highbeam.com/doc/1P2-15210.html
HSL1105
“Promoting Safe Prescription Drugs”
Drug Safety Canada 2005 Mar 16
HSL20072
Limprecht E
Software drug ad rules 'contradictory'
Australian Doctor 2005 Mar 16
HSL895
Appleby J.
FDA rejects Crestor petition
USA Today 2005 Mar 15
HSL902
Vault.com
Pharmaceuticals
College Journal from The Wall Street Journal 2005 Mar 15
HSL1030
Lexchin J.
Drug withdrawals from the Canadian market for safety reasons, 1963-2004.
CMAJ 2005 Mar 15;172:(6):765-7
http://www.cmaj.ca/cgi/content/full/172/6/765
HSL4787
Vazquez Gomez I, Fernandez-Llimos F, Gastelurrutia MA.
[Response of the pharmaceutical industry to a specific consultation].
Aten Primaria 2005 Mar 15;35:(4):219-20
http://www.ncbi.nlm.nih.gov/pubmed/15766501
HSL904
Schafer A.
Can your doctor be bought for a dinner?
2005 Mar 14
HSL911
Rubin R.
A spoonful of satire helps 'Side Effects'
USA Today 2005 Mar 14
HSL893
Japsen B.
FDA weighs decision on Meridia: Health advisory likely for Abbott obesity drug
Chicago Tribune 2005 Mar 13
HSL890
Foreign nations lobbying for patents law
Sify.com 2005 Mar 11
HSL853
Willman D.
Three Researchers in NIH Controversy Are Leaving:Their paid consulting for the drug industry is central to the issue of professional conflicts at the agency, which is banning such income.
THE LOS ANGELES TIMES 2005 Mar 10
HSL854
Angell M.
What ails the FDA? Payola
The New York Times 2005 Mar 10
HSL855
Henderson D.
FDA piles initiatives on the back burner: Pressing drug safety problems divert the agency's attention from longer-term issues awaiting action
The Boston Globe 2005 Mar 10
HSL882
Costello D.
Little pills can lead to big problems: 'Ritalin generation' has discovered prescription drugs as a new high
Los Angeles Times 2005 Mar 10
Page 129 of 206 pages ‹ First < 127 128 129 130 131 > Last ›
